EFFECTIVENESS OF MINDFULNESS-BASED STRESS REDUCTION PROGRAMS ON CHRONIC PAIN, QUALITY OF LIFE, AND PSYCHOLOGICAL WELL-BEING IN PATIENTS WITH CHRONIC PAIN

Main Article Content

Nusrum Iqbal
Dr Sadia Nawaz
Wajiha Khan
Rabiullah Ghafoori
Manusche Ibbad
Omema Rathore
Muhammed Saad Nagi
Elsa Zainab Ansari
Mian Mukhtar ul Haq

Keywords

.

Abstract

Introduction:  In recent years, mindfulness-based interventions have gained increasing popularity in the field of pain management, particularly for individuals dealing with chronic conditions. Objective: The main objective of the study is to find the effectiveness of mindfulness-based stress reduction programs on chronic pain, quality of life, and psychological well-being in patients with chronic pain. Methodology: This retrospective observational study was conducted at MD Health Center, Lahore from May 2023 to January 2024. A total of 127 patients diagnosed with chronic pain were recruited from pain management clinics, primary care facilities, and online platforms targeting individuals with long-term pain conditions. Results: Data were collected from 127 patients with a mean age of 45.6 ± 12.1 years across groups (45.2 ± 12.3 years in the intervention group and 46.1 ± 11.8 years in the control group). Gender distribution was similar, with females comprising 54.3% (34 in intervention, 35 in control) and males 45.7% (30 in intervention, 28 in control). Chronic pain duration varied, with 52.0% of participants experiencing pain for over a year (32 in intervention, 34 in control). Primary pain locations were mainly the back (38.6%), followed by limbs (22.0%) and neck (20.5%). Baseline measures, including pain intensity (6.55 ± 1.2), quality of life (52.65 ± 8.1), anxiety (10.2 ± 2.25), depression (9.6 ± 2.55), emotional regulation (45.15 ± 6.25), and resilience (25.4 ± 5.45), were comparable across both groups, indicating balanced characteristics before the intervention. The intervention group demonstrated a significant reduction in pain intensity from a pretest mean of 6.5 ± 1.2 to a posttest mean of 4.2 ± 1.1, with a t-value of 8.4 and a p-value of < .001, indicating a large effect size (Cohen’s d = 1.1).Conclusion: It is concluded that Mindfulness-Based Stress Reduction (MBSR) is an effective intervention for managing chronic pain, enhancing quality of life, and improving psychological well-being. The program provides a holistic, non-pharmacological approach that empowers patients to develop healthier responses to pain.

Abstract 143 | pdf Downloads 29

References

1. Harris K, Jackson J, Webster H, Farrow J, Zhao Y, Hohmann L. Mindfulness-Based Stress Reduction (MBSR) for Chronic Pain Management in the Community Pharmacy Setting: A Cross-Sectional Survey of the General Public's Knowledge and Perceptions. Pharmacy (Basel). 2023 Sep 21;11(5):150. doi: 10.3390/pharmacy11050150. PMID: 37736922; PMCID: PMC10514835.
2. Cohen SP, Vase L, Hooten WM. Chronic pain: An update on burden, best practices, and new advances. Lancet. 2021;397:2082–2097. doi: 10.1016/S0140-6736(21)00393-7.
3. Yong RJ, Mullins PM, Bhattacharyya N. Prevalence of chronic pain among adults in the United States. Pain. 2022;163–e332. doi: 10.1097/j.pain.0000000000002291.
4. Volkow ND, McLellan AT. Mitigation strategies for opioid abuse. N Engl J Med. 2016;375:96. doi: 10.1056/NEJMc1605652.
5. Centers for Disease Control and Prevention. U.S. Opioid Dispensing Rate Maps. Available from: https://www.cdc.gov/drugoverdose/rxrate-maps/index.html. Accessed July 5, 2023.
6. Centers for Disease Control and Prevention. Death Rate Maps & Graphs. Available from: https://www.cdc.gov/drugoverdose/deaths/index.html. Accessed July 5, 2023.
7. Hilton L, Hempel S, Ewing BA, Apaydin E, Xenakis L, Newberry S, et al. Mindfulness meditation for chronic pain: Systematic review and meta-analysis. Ann Behav Med. 2017;51:199–213. doi: 10.1007/s12160-016-9844-2.
8. Cherkin DC, Sherman KJ, Balderson BH, Cook AJ, Anderson ML, Hawkes RJ, et al. Effect of mindfulness-based stress reduction vs. cognitive behavioral therapy or usual care on back pain and functional limitations in adults with chronic low back pain: A randomized clinical trial. JAMA. 2016;315:1240–1249. doi: 10.1001/jama.2016.2323.
9. Qaseem A, Wilt TJ, McLean RM, Forciea MA, Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166:514–530. doi: 10.7326/M16-2367.
10. Shergill Y, Rice DB, Khoo EL, Jarvis V, Zhang T, Taljaard M, et al. Mindfulness-based stress reduction in breast cancer survivors with chronic neuropathic pain: A randomized controlled trial. Pain Res Manag. 2022;2022:4020550. doi: 10.1155/2022/4020550.
11. Look KA, Kile M, Morgan K, Roberts A. Community pharmacies as access points for addiction treatment. Res Soc Adm Pharm. 2019;15:404–409. doi: 10.1016/j.sapharm.2018.06.006.
12. Hohmann LA, Krauss Z, Patel J, Marley GT. Public Perceptions of Community Pharmacy-Based Naloxone Services: A National Cross-Sectional Survey. Pharmacy (Basel). 2022 Dec 9;10(6):171. doi: 10.3390/pharmacy10060171. PMID: 36548327; PMCID: PMC9781939.
13. Wells RE, O'Connell N, Pierce CR, Estave P, Penzien DB, Loder E, Zeidan F, Houle TT. Effectiveness of Mindfulness Meditation vs Headache Education for Adults With Migraine: A Randomized Clinical Trial. JAMA Intern Med. 2021 Mar 1;181(3):317-328. doi: 10.1001/jamainternmed.2020.7090. PMID: 33315046; PMCID: PMC7737157.
14. Seminowicz DA, Burrowes SAB, Kearson A, et al. . Enhanced mindfulness-based stress reduction in episodic migraine: a randomized clinical trial with magnetic resonance imaging outcomes. Pain. Published online March 13, 2020. doi: 10.1097/j.pain.0000000000001860
15. Dodick DW, Silberstein SD, Bigal ME, et al. Effect of fremanezumab compared with placebo for prevention of episodic migraine: a randomized clinical trial. JAMA. 2018;319(19):1999-2008. doi: 10.1001/jama.2018.4853
16. Grazzi L, Bernstein C, Raggi A, et al. ACT for migraine: effect of acceptance and commitment therapy (ACT) for high-frequency episodic migraine without aura: preliminary data of a phase-II, multicentric, randomized, open-label study. Neurol Sci. 2019;40(suppl 1):191–192.
17. Kuruvilla D, Wells RE. Evidence-based integrative treatments for headache. Headache. 2019;59(6):971–972. doi: 10.1111/head.13555.
18. Wells RE, Strauss LD. The value of headache-specific recommendations during COVID-19. Headache. 2020;60(5):820–823. doi: 10.1111/head.13821.
19. Chowdhury D, Datta D. Managing migraine in the times of COVID-19 pandemic. Ann Indian Acad Neurol. 2020;23(suppl 1)–S39.
20. Crane RS, Hecht FM. Intervention integrity in mindfulness-based research. Mindfulness (N Y). 2018;9(5):1370-1380. doi: 10.1007/s12671-018-0886-3